The Effects of Rosmarinic Acid on Hippocampal Oxidative Stress Markers in LPS-induced Neuroinflammation Rats Rosmarinic Acid and Hippocampal Oxidative Stress
Iranian Journal of Pharmaceutical Sciences,
دوره 17 شماره 2 (2021),
1 April 2021
,
صفحه 117-128
https://doi.org/10.22037/ijps.v17.40290
چکیده
Neuroinflammation (NI) plays a pivotal role in the pathogenesis of several neurodegenerative diseases. It has been believed that alleviating NI can be a valuable approach in controlling the progress of neurodegenerative diseases. The generation of reactive oxygen and nitrogen species could trigger and deteriorate NI. According to previous studies, rosmarinic acid (RA) could exhibit neuroprotective potential. Therefore, this study aimed to evaluate the effect of RA on hippocampal oxidative stress markers in lipopolysaccharide (LPS)-induced NI in rat brain. A total of 24 adult male Wistar rats were randomly allocated into four equal groups (n=6 each) and NI was induced in three of them by intracerebroventricular (ICV) injection of LPS (50 μg/20μl; 10 μl into each ventricle). RA (2.5-5 mg/kg i.p.) was injected 30 min before the LPS injection and continued once per day up to 48 h. On day 3, animals were sacrificed and their hippocampi were dissected. Then, hippocampal concentrations of malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NOx) were determined. RA prevented hippocampal MDA elevation in a dose-dependent-manner and increased SOD activity but did not affect NOx content. In conclusion, the results of the present study demonstrated that systemic administration of RA could effectively ameliorate oxidative stress induced by LPS in rat’s brain. This potential might be one of the underlying mechanisms through which RA mitigates NI.
- Innate Inflammatory Response
- Neurodegenerative diseases
- Hippocampus
- Oxidative Stress
- Lipopolysaccharides
- Rosmarinic Acid
ارجاع به مقاله
مراجع
[2] Leszek J, E Barreto G, Gasiorowski K, Koutsouraki E and Aliev G. Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system. CNS. Neurol. Disord. Drug. Targets (2016) 3: 329-336.
[3] Gendelman HE and Benner EJ. Control of Neuroinflammation for Therapeutic Gain. in: Ikezu T and Gendelman HE. (eds.) Neuroimmune Pharmacology. 2nd ed. Springer International Publishing, Cham ( 2017) 971-978.
[4] Via MA and Mechanick JI. Mechanisms of Nontraditional and Lifestyle Interventions for Bone Health. in: Zaidi M. (ed.) Encyclopedia of Bone Biology. 1st ed. Academic Press, Oxford (2020) 730-749.
[5] Luo C, Zou L, Sun H, Peng J, Gao C, Bao L, Ji R, Jin Y and Sun SA. Review of the Anti-Inflammatory Effects of Rosmarinic Acid on Inflammatory Diseases. Front. Pharmacol. (2020)11:153.
[6] Adomako-Bonsu AG, Chan SL, Pratten M and Fry JR. Antioxidant activity of rosmarinic acid and its principal metabolites in chemical and cellular systems: Importance of physico-chemical characteristics. Toxicol. in Vitro (2017) 40 :248-255.
[7] Gamaro GD, Suyenaga E, Borsoi M, Lermen J, Pereira P and Ardenghi P. Effect of Rosmarinic and Caffeic Acids on Inflammatory and Nociception Process in Rats. ISRN. Pharmacol. (2011) 2011: 451682.
[8] Zych M, Kaczmarczyk-Sedlak I, Wojnar W, Folwarczna J. Effect of Rosmarinic Acid on the Serum Parameters of Glucose and Lipid Metabolism and Oxidative Stress in Estrogen-Deficient Rats. Nutrients (2019) 2: 267.
[9] Fachel FN, Schuh RS, Veras KS, Bassani VL, Koester LS, Henriques AT, Braganhol E and Teixeira HF. An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating neurodegenerative disorders. Neurochem. Int. (2019) 122:77-58.
[10] Hase T, Shishido S, Yamamoto S, Yamashita R, Nukima H, Taira S, Toyoda T, Abe K, Hamaguchi T, Ono K and Noguchi-Shinohara M. Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid β aggregation by increasing monoamine secretion. Sci. Rep. (2019) 1: 8711.
[11] Geurts JJ, Bö L, Roosendaal SD, Hazes T, Daniëls R, Barkhof F, Witter MP, Huitinga I and van der Valk P. Extensive hippocampal demyelination in multiple sclerosis. J. Neuropathol. Ex. Neurol. (2007) 9: 819-827.
[12] Moodley KK and Chan D. The hippocampus in neurodegenerative disease. Front. Neurol. Neurosci. (2014) 34:95-108.
[13] Rezaei F, Saebipour MR, Ghaemi K, Hassanzadeh-Taheri MM, Foadoddini M and Hosseini M. Intra-cerebroventricular Administration of Crocin Attenuates Sleep Deprivation-induced Hyperalgesia in Rats. Basic Clin. Neurosci. (2020) 3:261-268.
[14] Tyagi E, Agrawal R, Nath C and Shukla R. Inhibitory role of cholinergic system mediated via α7 nicotinic acetylcholine receptor in LPS-induced neuro-inflammation. Innate immun. (2010) 1:3-13.
[15] Bahri S, Mies F, Ben Ali R, Mlika M, Jameleddine S, Mc Entee K and Shlyonsky V. Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts. PloS one. (2017) 9:e0184368.
[16] Li GS, Jiang WL, Tian JW, Qu GW, Zhu HB and Fu FH. In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Phytomedicine (2010) 3-4:282-8.
[17] Ataie Z, Mehrani H, Ghasemi A and Farrokhfall K. Cinnamaldehyde has beneficial effects against oxidative stress and nitric oxide metabolites in the brain of aged rats fed with long-term, high-fat diet. J. Funct. Foods (2019) 52 :545-551.
[18] Moodi H, Hosseini M, Abedini MR, Hassanzadeh-Taheri M and Hassanzadeh-Taheri M. Ethanolic extract of Iris songarica rhizome attenuates methotrexate-induced liver and kidney damages in rats. Avicenna J. Phytomed. (2020) 4: 372-383.
[19] Hoshyar R, Sebzari A, Balforoush M, Valavi M and Hosseini M. The impact of Crocus sativus stigma against methotrexate-induced liver toxicity in rats. J. Complement. Integr. Med. (2020) 2: 20190201.
[20] Nava Catorce M and Gevorkian G. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals. Curr. Neuropharmacol. (2016) 2: 155-164.
[21] Graeber MB, Li W and Rodriguez ML. Role of microglia in CNS inflammation. FEBS. Let. (2011) 23: 3798-3805.
[22] Krause DL and Müller N. Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int. J. Alzheimers Dis. (2010): 2010:732806.
[23] Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ and Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. (2002) 7: 2478-2486.
[24] Mrak RE and Griffin WS. Glia and their cytokines in progression of neurodegeneration. Neurobiol. aging (2005) 3: 349-354.
[25] Zhao J, Bi W, Xiao S, Lan X, Cheng X, Zhang J, Lu D, Wei W, Wang Y, Li H and Fu Y. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci. Rep. (2019) 1: 5790.
[26] Allison DJ and Ditor DS. The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J. Neuroinflammation (2014) 11: 151.
[27] Zhu X, Liu J, Chen S, Xue J, Huang S, Wang Y and Chen O. Chen. Isoliquiritigenin attenuates lipopolysaccharide-induced cognitive impairment through antioxidant and anti-inflammatory activity. BMC. neuroscience (2019) 1: 41.
[28] Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA and Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. (2007) 10:766-775.
[29] Huang N, Hauck C, Yum MY, Rizshsky L, Widrlechner MP, McCoy JA, Murphy PA, Dixon PM, Nikolau BJ and Birt DF. Rosmarinic acid in Prunella vulgaris ethanol extract inhibits lipopolysaccharide-induced prostaglandin E2 and nitric oxide in RAW 264.7 mouse macrophages. J. Agric. Food Chem. (2009) 22: 10579-10589.
[30] So Y, Lee SY, Han AR, Kim JB, Jeong HG and Jin CH. Rosmarinic acid methyl ester inhibits LPS-induced NO production via suppression of MyD88-dependent and-independent pathways and induction of HO-1 in RAW 264.7 cells. Molecules (2016) 8: 1083.
[31] Taram F, Ignowski E, Duval N and Linseman DA. Neuroprotection comparison of rosmarinic acid and carnosic acid in primary cultures of cerebellar granule neurons. Molecules (2018) 11: 2956.
[32] Hasanein P, Seifi R, Hajinezhad MR and Emamjomeh A. Rosmarinic acid protects against chronic ethanol-induced learning and memory deficits in rats. Nutr. Neurosci (2017) 9: 547-554.
[33] Wei Y, Chen J, Hu Y, Lu W, Zhang X, Wang R and Chu K. Rosmarinic acid mitigates lipopolysaccharide-induced neuroinflammatory responses through the inhibition of TLR4 and CD14 expression and NF-κB and NLRP3 inflammasome activation. Inflammation (2018) 2: 732-740.
[34] Bacanlı M, Aydın S, Taner G, Göktaş HG, Şahin T, Başaran AA, Başaran N. Does rosmarinic acid treatment have protective role against sepsis-induced oxidative damage in Wistar Albino rats? Hum. Exp. Toxicol (2016) 8: 877-886.
[35] Fernando PM, Piao MJ, Kang KA, Ryu YS, Hewage SR, Chae SW and Hyun JW. Rosmarinic acid attenuates cell damage against UVB radiation-induced oxidative stress via enhancing antioxidant effects in human HaCaT cells. Biomol. Ther. (Seoul) (2016) 1: 75-84.
[36] Jiang K, Ma X, Guo S, Zhang T, Zhao G, Wu H, Wang X and Deng G. Anti-inflammatory effects of rosmarinic acid in lipopolysaccharide-induced mastitis in mice. Inflammation (2018) 2: 437-448.
[37] Mushtaq N, Schmatz R, Ahmed M, Pereira LB, da Costa P, Reichert KP, Dalenogare D, Pelinson LP, Vieira JM, Stefanello N and de Oliveira LS. Protective effect of rosmarinic acid against oxidative stress biomarkers in liver and kidney of strepotozotocin-induced diabetic rats. J. Physiol. Biochem. (2015) 4: 743-751.
[38] Mushtaq N, Schmatz R, Pereira LB, Ahmad M, Stefanello N, Vieira JM, Abdalla F, Rodrigues MV, Baldissarelli J, Pelinson LP and Dalenogare DP. Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin‐induced diabetic rats. Cell Biochem. Funct. (2014) 3: 287-293.
- چکیده مشاهده شده: 91 بار
- IJPS_Volume 17_Issue 2_Pages 117-128 (English) دانلود شده: 32 بار